Kaposiform Hemangioendothelioma

Common Name(s)

Kaposiform Hemangioendothelioma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Kaposiform Hemangioendothelioma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Kaposiform Hemangioendothelioma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Kaposiform Hemangioendothelioma" returned 11 free, full-text research articles on human participants. First 3 results:

Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals.
 

Author(s): Stacy E Croteau, Marilyn G Liang, Harry P Kozakewich, Ahmad I Alomari, Steven J Fishman, John B Mulliken, Cameron C Trenor

Journal: J. Pediatr.. 2013 Jan;162(1):142-7.

 

To examine the presentation characteristics of patients with Kaposiform hemangioendothelioma (KHE) to describe the spectrum of disease and risk factors for Kasabach-Merritt phenomenon (KMP).

Last Updated: 24 Dec 2012

Go To URL
Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
 

Author(s): Yvonne E Chiu, Beth A Drolet, Francine Blei, Manuel Carcao, Jason Fangusaro, Michael E Kelly, Alfons Krol, Sabra Lofgren, Anthony J Mancini, Denise W Metry, Michael Recht, Robert A Silverman, Wynnis L Tom, Elena Pope

Journal: Pediatr Blood Cancer. 2012 Nov;59(5):934-8.

 

Propranolol is a non-selective beta-adrenergic antagonist successfully used in a case of kaposiform hemangioendothelioma (KHE) associated with Kasabach-Merritt phenomenon (KMP). We report 11 patients treated with propranolol for KHE and the related variant tufted angioma (TA), six ...

Last Updated: 13 Sep 2012

Go To URL
Kaposiform hemangioendothelioma in tonsil of a child associated with cervical lymphangioma: a rare case report.
 

Author(s): Bharat Rekhi, Shweta Sethi, Suyash S Kulkarni, Nirmala A Jambhekar

Journal:

 

Kaposiform hemangioendothelioma (KHE) is an uncommon vascular tumor of intermediate malignant potential, usually occurs in the extremities and retroperitoneum of infants and is characterized by its association with lymphangiomatosis and Kasabach-Merritt phenomenenon (KMP) in certain ...

Last Updated: 20 Jun 2011

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Kaposiform Hemangioendothelioma" returned 0 free, full-text review articles on human participants.

 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
 

Status: Not yet recruiting

Condition Summary: Kaposiform Hemangioendothelioma (KHE); Kasabach-Merritt Syndrome; Tufted Angioma

 

Last Updated: 14 Nov 2014

Go to URL